Palisade Capital Management, LLC today announced that it sold a majority interest in Shoe Sensation, a leading family footwear retailer in the Midwestern United States, to J.W. Childs Associates, L.P. Financial terms of the investment were not disclosed. “Shoe Sensation has experienced over six consecutive years of comparable store revenue growth and, since 2010, has grown from 62 locations in 10 states to 115 stores in 17 states,” said Jeffrey Serkes, Chief Operating Officer of Palisade Capital. “It has been a pleasure working with the company’s management team over the past several years, as both they and Shoe Sensation’s employees have built a terrific culture that has the company poised for continued success.”
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced the signing of an exclusive license and development agreement for BBI-4000 with Kaken Pharmaceutical Co., Ltd. (“Kaken”), a top-tier specialty pharmaceutical company in Japan with strong experience in developing and commercializing novel dermatological drugs.
Brickell Biotech, Inc. (“Brickell”), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced a $10 million Series C financing round (the “Offering”). Brickell’s pipeline includes new molecular entities in dermatology for hyperhidrosis, atopic dermatitis, and acne.
Sharecare, a comprehensive health and wellness engagement platform, today announced the acquisition of QualityHealth, a platform for identifying patients at large scale, and activating them to take relevant health-specific actions. As one of the industry’s largest permission-based databases, QualityHealth has more than 50 million registered members and touches 100 million health consumers each month across 175 different health, wellness and therapeutic categories. PPPII will continue to own Sharecare equity post-closing.
The lockdowns and flash recession which followed the beginning of the COVID-19 pandemic precipitated a reset of the global economy and initiated a new business cycle. Recent stock market weakness, however, is a cyclical correction in a secular bull market, and we believe the U.S. remains early in the recovery phase of this new cycle.
Neither rankings and/or recognition by unaffiliated rating services, publications, media, or other organizations, nor the achievement of any designation or certification, should be construed as a guarantee that a client or prospective client will experience any certain level of results if Palisade Capital Management, L.L.C. (“Palisade”) is engaged, or continues to be engaged, to provide investment advisory services. Rankings published by third parties generally base their selections exclusively on information prepared and/or submitted by the recognized adviser. Rankings are generally limited to participating advisers. Unless expressly indicated to the contrary, Palisade did not pay a fee to be included in any such ranking. No ranking or recognition should be construed as a current or past endorsement of Palisade by any of its clients.